Search results
How Long Should I Stay on Ozempic For Weight Loss?
MediaFeed via AOL· 13 hours agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid answer to this question yet.
Weight loss medication complete guide: From Wegovy to Mounjaro
The Telegraph via Yahoo News· 3 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 2 days agoHowever, another drug designed to assist with type 2 diabetes treatment, metformin, had a 13-year...
Biomea Fusion Crashes 63% After FDA Puts Diabetes Treatment Studies On Hold
Investor's Business Daily· 10 hours agoThe drug, BMF-291, was in early-stage testing for patients with type 1 and type 2 diabetes. The FDA...
Analysis | Weight-loss drugs are so popular they’re headed for Medicare negotiations
Washington Post· 19 hours agoToday’s edition: Conservative policymakers with ties to former president Donald Trump want to limit...
Researchers determine timing is key for type 2 diabetes drug performance
Medical Xpress· 13 hours agoDr. Cong Xie postdoctoral research fellow in the Centre of Research Excellence in Translating Nutritional Science to Good Health, at Adelaide Medical School, worked with Associate Professor ...
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials - Biomea Fusion...
Benzinga· 20 hours agoWhat Happened: The FDA’s decision was driven by concerns over potential drug-induced hepatotoxicity...
Popular diet and diabetes drugs in short supply as demand surges
AOL· 4 days agoWeight loss drugs like Ozempic, Wegovy and Zepbound continue to be in short supply. The weekly...
FDA places full clinical hold on Biomea Fusion’s diabetes trials of BMF-219
Clinical Trials Arena via Yahoo Finance· 22 hours agoThe double-blind, placebo-controlled COVALENT-112 trial is designed to assess BMF-219 in 150 adults...
Eli Lilly Is Trading At A Record High Ahead Of A Key FDA Meeting — Is It A Buy?
Investor's Business Daily· 12 hours agoShares of companies working on treatments for metabolic dysfunction-associated steatohepatitis, or...